Annual EPS
$3.66$2.07+130.33%
Summary
- Current Value
- As of today, GSK annual EPS is $3.66, up +130.33% on
- Historical Performance
- GSK annual EPS is down -59.44% over the past 3 years, up +0.03% over the past 5 years
- All-Time High Comparison
- GSK annual EPS is currently -59.44% below its historical high of $9.02 set on
- 3-Year Low Comparison
- GSK annual EPS is +130.33% above its 3-year low of $1.59 reached on
- Sector Comparison
- GSK annual EPS is higher than 93.31% of companies in Healthcare sector
- Upcoming Earnings
- The next annual earnings release for GSK is on
EPS Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | $3.66 | +130.3% | -59.4% | +0.0% | +197.3% | |
| Quarterly EPS | $1.02 | -23.1% | +13.0% | +28.3% | -6.9% | |
| TTM EPS | $2.87 | -18.2% | -21.1% | -2.3% | +9.0% | |
| Price | $49.13 | +4.8% | +43.8% | +12.6% | +11.4% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| PE Ratio | 17.13 | +28.1% | +82.4% | +15.3% | +2.2% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual Gross Profit | $30.76B | +9.9% | +28.3% | +3.8% | -3.6% | |
| Shares Outstanding | 2.00B | -0.5% | -1.2% | +0.0% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.02 | N/A | -59.4% |
| 5Y | $9.02 | -59.4% | |
| All | $9.02 | -59.4% |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.59 | +130.3% | |
| 5Y | $1.59 | +130.3% | |
| All | $0.63 | +484.8% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $2.98 | - | |
| - | $1.59 | - | |
| - | $3.66 | - |
🔒 Log In To Unlock Full Data
EPS History
FAQ
- What is the current annual EPS of GSK?
- As of today, GSK annual EPS is $3.66
- What is 1-year change in GSK annual EPS?
- GSK annual EPS is up +130.33% year-over-year
- What is 3-year change in GSK annual EPS?
- GSK annual EPS is down -59.44% over the past 3 years
- How far is GSK annual EPS from its all-time high?
- GSK annual EPS is currently -59.44% below its historical high of $9.02 set on December 31, 2022
- How does GSK annual EPS rank versus sector peers?
- GSK annual EPS is higher than 93.31% of companies in Healthcare sector
- When is GSK next annual earnings release?
- The next annual earnings release for GSK is on
EPS Formula
EPS =
Quarterly EPS
$1.02$0.73+254.19%
Summary
- Current Value
- As of today, GSK quarterly EPS is $1.02, up +254.19% on
- Historical Performance
- GSK quarterly EPS is down -23.07% year-over-year, up +13.01% over the past 3 years
- All-Time High Comparison
- GSK quarterly EPS is currently -83.80% below its historical high of $6.28 set on
- 3-Year Low Comparison
- GSK quarterly EPS is +2852.16% above its 3-year low of -$0.04 reached on
- Sector Comparison
- GSK quarterly EPS is higher than 91.67% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $1.02 | +254.2% | -23.1% | +13.0% | +28.3% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| TTM EPS | $2.87 | -9.6% | -18.2% | -21.1% | -2.3% | |
| Price | $49.13 | -5.0% | +4.8% | +43.8% | +12.6% | |
| Quarterly Revenue | $11.94B | +5.8% | +3.6% | +15.8% | +30.8% | |
| PE Ratio | 17.13 | +5.2% | +28.1% | +82.4% | +15.3% | |
| Quarterly Net Income | $2.29B | +208.4% | -20.8% | +17.9% | +75.6% | |
| Quarterly Gross Profit | $8.89B | +5.0% | +4.5% | +19.4% | +38.6% | |
| Shares Outstanding | 2.00B | – | -0.5% | -1.2% | +0.0% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.32 | N/A | -23.1% |
| 3Y | $1.32 | -23.1% | |
| 5Y | $6.23 | -83.7% | |
| All | $6.28 | -83.8% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.29 | +254.2% | |
| 3Y | -$0.04 | +2852.2% | |
| 5Y | -$0.04 | +2852.2% | |
| All | -$0.53 | +293.1% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.41 | - | |
| - | $1.15 | - | |
| - | $0.29 | - | |
| - | $1.02 | - |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
- What is the current quarterly EPS of GSK?
- As of today, GSK quarterly EPS is $1.02
- What is GSK quarterly EPS most recent change?
- GSK quarterly EPS was up +254.19% on September 30, 2026
- What is 1-year change in GSK quarterly EPS?
- GSK quarterly EPS is down -23.07% year-over-year
- How far is GSK quarterly EPS from its all-time high?
- GSK quarterly EPS is currently -83.80% below its historical high of $6.28 set on March 31, 2015
- How does GSK quarterly EPS rank versus sector peers?
- GSK quarterly EPS is higher than 91.67% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
EPS Formula
EPS =
TTM EPS
$2.87$0.31-9.62%
Summary
- Current Value
- As of today, GSK TTM EPS is $2.87, down -9.62% on
- Historical Performance
- GSK TTM EPS is down -18.18% year-over-year, down -21.15% over the past 3 years
- All-Time High Comparison
- GSK TTM EPS is currently -68.00% below its historical high of $8.96 set on
- 3-Year Low Comparison
- GSK TTM EPS is +86.65% above its 3-year low of $1.54 reached on
- Sector Comparison
- GSK TTM EPS is higher than 90.91% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $2.87 | -9.6% | -18.2% | -21.1% | -2.3% | |
| Quarterly EPS | $1.02 | +254.2% | -23.1% | +13.0% | +28.3% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| Price | $49.13 | -5.0% | +4.8% | +43.8% | +12.6% | |
| TTM Revenue | $44.97B | +0.9% | +6.9% | +23.6% | +15.1% | |
| PE Ratio | 17.13 | +5.2% | +28.1% | +82.4% | +15.3% | |
| TTM Net Income | $6.48B | -8.5% | -18.7% | -19.2% | +9.3% | |
| TTM Gross Profit | $33.04B | +1.2% | +8.4% | +25.9% | +23.8% | |
| Shares Outstanding | 2.00B | – | -0.5% | -1.2% | +0.0% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.82 | -25.0% | |
| 3Y | $3.82 | -25.0% | |
| 5Y | $8.96 | -68.0% | |
| All | $8.96 | -68.0% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.87 | at low | |
| 3Y | $1.54 | +86.7% | |
| 5Y | $1.54 | +86.7% | |
| All | $0.00 | N/A |
TTM EPS History
FAQ
- What is the current TTM EPS of GSK?
- As of today, GSK TTM EPS is $2.87
- What is GSK TTM EPS most recent change?
- GSK TTM EPS was down -9.62% on September 30, 2026
- What is 1-year change in GSK TTM EPS?
- GSK TTM EPS is down -18.18% year-over-year
- How far is GSK TTM EPS from its all-time high?
- GSK TTM EPS is currently -68.00% below its historical high of $8.96 set on June 30, 2023
- How does GSK TTM EPS rank versus sector peers?
- GSK TTM EPS is higher than 90.91% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
EPS Formula
EPS =
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk
